{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:51:31Z","timestamp":1790484691967,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejca.2017.10.030","type":"journal-article","created":{"date-parts":[[2017,11,26]],"date-time":"2017-11-26T00:51:22Z","timestamp":1511657482000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9119-8328","authenticated-orcid":false,"given":"M.","family":"Timmermans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.S.","family":"Sonke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.K.","family":"Van de Vijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"van der Aa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1305-9541","authenticated-orcid":false,"given":"R.F.P.M.","family":"Kruitwagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejca.2017.10.030_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bpobgyn.2005.10.007","article-title":"Worldwide burden of gynaecological cancer: the size of the problem","volume":"20","author":"Sankaranarayanan","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"15","key":"10.1016\/j.ejca.2017.10.030_bib2","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.ejca.2015.07.022","article-title":"Survival of women with cancers of breast and genital organs in Europe 1999\u20132007: results of the EUROCARE-5 study","volume":"51","author":"Sant","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2017.10.030_bib3","series-title":"SEER cancer statistics review","author":"Howlader","year":"1975"},{"issue":"1","key":"10.1016\/j.ejca.2017.10.030_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/CEJ.0b013e3283552e28","article-title":"Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stage","volume":"22","author":"Chen","year":"2013","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.ejca.2017.10.030_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejca.2016.07.015","article-title":"The impact of lymph node dissection and adjuvant chemotherapy on survival: a nationwide cohort study of patients with clinical early-stage ovarian cancer","volume":"66","author":"Kleppe","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2017.10.030_bib6","first-page":"CD004706","article-title":"Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer","volume":"12","author":"Lawrie","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ejca.2017.10.030_bib7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","article-title":"The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma","volume":"170","author":"Hoskins","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejca.2017.10.030_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","article-title":"Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis","volume":"130","author":"Chang","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2017.10.030_bib9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"issue":"9990","key":"10.1016\/j.ejca.2017.10.030_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejca.2017.10.030_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/annonc\/mdn639","article-title":"Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis","volume":"20","author":"Gondos","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2017.10.030_bib12","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1097\/CEJ.0000000000000302","article-title":"Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study","volume":"26","author":"Chirlaque","year":"2017","journal-title":"Eur J Cancer Prev"},{"issue":"4","key":"10.1016\/j.ejca.2017.10.030_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/0284186X.2011.653437","article-title":"Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade","volume":"51","author":"Oberaigner","year":"2012","journal-title":"Acta Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2017.10.030_bib14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3109\/02841861003691945","article-title":"Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964\u20132003 followed up to the end of 2006","volume":"49","author":"Klint","year":"2010","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2017.10.030_bib15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1186\/1471-2407-10-622","article-title":"Population-based study of ovarian cancer in Cote d'Or: prognostic factors and trends in relative survival rates over the last 20 years","volume":"10","author":"Hamidou","year":"2010","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2017.10.030_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ygyno.2015.09.013","article-title":"Ovarian cancer in France: trends in incidence, mortality and survival, 1980\u20132012","volume":"139","author":"Tretarre","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2017.10.030_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s004320050250","article-title":"Trends in survival of patients with ovarian cancer in Saarland, Germany, 1976\u20131995","volume":"125","author":"Brenner","year":"1999","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ejca.2017.10.030_bib18","first-page":"537","article-title":"Clinical epidemiology of epithelial ovarian cancer in the UK","volume":"6","author":"Doufekas","year":"2014","journal-title":"Int J Womens Health"},{"issue":"3","key":"10.1016\/j.ejca.2017.10.030_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ygyno.2012.02.033","article-title":"Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in The Netherlands","volume":"125","author":"van Altena","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2017.10.030_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/IGC.0000000000000858","article-title":"Time trends in ovarian cancer survival in Estonia by age and stage","volume":"27","author":"Ojamaa","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2017.10.030_bib21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1467-842X.2003.tb00604.x","article-title":"Ovarian cancer in Western Australia (1982\u201398): incidence, mortality and survival","volume":"27","author":"Laurvick","year":"2003","journal-title":"Aust N Z J Public Health"},{"issue":"4","key":"10.1016\/j.ejca.2017.10.030_bib22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/IGC.0b013e3181a3a436","article-title":"Reasons for improved survival from ovarian cancer in New South Wales, Australia, between 1980 and 2003: implications for cancer control","volume":"19","author":"Tracey","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2017.10.030_bib23","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1067\/S0002-9378(03)00579-9","article-title":"Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades","volume":"189","author":"Barnholtz-Sloan","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"3 Pt 1","key":"10.1016\/j.ejca.2017.10.030_bib24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.AOG.0000231680.58221.a7","article-title":"Patterns and progress in ovarian cancer over 14 years","volume":"108","author":"Chan","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejca.2017.10.030_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2011.07.098","article-title":"Temporal trends in the relative survival among patients diagnosed with ovarian cancer in Canada 1992\u20132005: a population-based study","volume":"123","author":"Akhtar-Danesh","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ejca.2017.10.030_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/0284186X.2015.1115119","article-title":"Trends in gynecologic cancer among elderly women in Denmark, 1980\u20132012","volume":"55","author":"Or Knudsen","year":"2016","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2017.10.030_bib27","doi-asserted-by":"crossref","first-page":"466","DOI":"10.12809\/hkmj-hkmms202112","article-title":"Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study","volume":"18","author":"Wong","year":"2012","journal-title":"Hong Kong Med J"},{"issue":"12","key":"10.1016\/j.ejca.2017.10.030_bib28","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1002\/ijc.26315","article-title":"Progress against cancer in The Netherlands since the late 1980s: an epidemiological evaluation","volume":"130","author":"Karim-Kos","year":"2012","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2017.10.030_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10552-017-0868-0","article-title":"Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future","volume":"28","author":"Webb","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"9980","key":"10.1016\/j.ejca.2017.10.030_bib30","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies","volume":"385","author":"Collaborative Group on Epidemiological Studies of Ovarian C","year":"2015","journal-title":"Lancet"},{"issue":"9609","key":"10.1016\/j.ejca.2017.10.030_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Collaborative Group on Epidemiological Studies of Ovarian C","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejca.2017.10.030_bib32","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ygyno.2016.04.012","article-title":"Improved outcomes due to changes in organization of care for patients with ovarian cancer in The Netherlands","volume":"141","author":"Eggink","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2017.10.030_bib33","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/0959-8049(95)00355-M","article-title":"Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries","volume":"31A","author":"van der Sanden","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2017.10.030_bib34","series-title":"International classification of diseases for oncology: ICD-O","author":"Fritz","year":"2000"},{"key":"10.1016\/j.ejca.2017.10.030_bib35","series-title":"International union against Cancer. TNM classification of malignant tumours","author":"Sobin","year":"2010"},{"issue":"3","key":"10.1016\/j.ejca.2017.10.030_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.critrevonc.2005.04.008","article-title":"Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach","volume":"55","author":"Janssen-Heijnen","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.ejca.2017.10.030_bib37","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1186\/s12885-016-2967-9","article-title":"Analysing population-based cancer survival \u2013 settling the controversies","volume":"16","author":"Pohar Perme","year":"2016","journal-title":"BMC Cancer"},{"issue":"32","key":"10.1016\/j.ejca.2017.10.030_bib38","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1200\/JCO.2016.68.1239","article-title":"Use and effectiveness of neoadjuvant chemotherapy for treatment of ovarian cancer","volume":"34","author":"Meyer","year":"2016","journal-title":"J Clin Oncol"},{"issue":"31","key":"10.1016\/j.ejca.2017.10.030_bib39","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.2011.35.9935","article-title":"Is the easier way ever the better way?","volume":"29","author":"Chi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2017.10.030_bib40","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ygyno.2014.07.004","article-title":"The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer","volume":"134","author":"Rosen","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2017.10.030_bib41","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1097\/IGC.0000000000000241","article-title":"Primary surgery or interval debulking for advanced epithelial ovarian cancer: does it matter?","volume":"24","author":"Markauskas","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2017.10.030_bib42","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ygyno.2007.02.030","article-title":"The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review","volume":"105","author":"Vernooij","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2017.10.030_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2016.05.025","article-title":"Centralized primary care of advanced ovarian cancer improves complete cytoreduction and survival \u2013 a population-based cohort study","volume":"142","author":"Dahm-Kahler","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"25","key":"10.1016\/j.ejca.2017.10.030_bib44","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJM198506203122504","article-title":"The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer","volume":"312","author":"Feinstein","year":"1985","journal-title":"N Engl J Med"},{"issue":"9760","key":"10.1016\/j.ejca.2017.10.030_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(10)62231-3","article-title":"Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995\u20132007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data","volume":"377","author":"Coleman","year":"2011","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.ejca.2017.10.030_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/CLEP.S20621","article-title":"Survival of patients with ovarian cancer in central and northern Denmark, 1998\u20132009","volume":"3","author":"Grann","year":"2011","journal-title":"Clin Epidemiol"},{"issue":"22","key":"10.1016\/j.ejca.2017.10.030_bib47","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1002\/cncr.25537","article-title":"TNM seventh edition: what's new, what's changed: communication from the International Union against Cancer and the American Joint Committee on Cancer","volume":"116","author":"Sobin","year":"2010","journal-title":"Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917313709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917313709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T18:18:13Z","timestamp":1659982693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804917313709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":47,"alternative-id":["S0959804917313709"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.10.030","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}